Form 8-K - Current report:
SEC Accession No. 0001654954-18-013564
Filing Date
2018-12-04
Accepted
2018-12-04 16:45:32
Documents
10
Period of Report
2018-12-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc8k.htm 8-K 30567
2 PRESENTATION ex99-1.htm EX-99.1 7697
3 IMAGE ex99-1000.jpg GRAPHIC 80878
4 IMAGE ex99-1001.jpg GRAPHIC 104879
5 IMAGE ex99-1002.jpg GRAPHIC 76208
6 IMAGE ex99-1003.jpg GRAPHIC 86498
7 IMAGE ex99-1004.jpg GRAPHIC 115963
8 IMAGE ex99-1005.jpg GRAPHIC 70273
9 IMAGE ex99-1006.jpg GRAPHIC 87656
10 IMAGE ex99-1007.jpg GRAPHIC 84146
  Complete submission text file 0001654954-18-013564.txt   1013323
Mailing Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618
Business Address 10005 MUIRLANDS BLVD. STE. G, FIRST FLOOR IRVINE CA 92618 949-419-0288
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 181217382
SIC: 2833 Medicinal Chemicals & Botanical Products